<PAGE> 1
Transcend Therapeutics, Inc.
640 Memorial Drive
3rd Floor West
Cambridge, MA 02139
December 18, 1996
VIA TELECOPIER AND EDGAR
- ------------------------
Mr. Robert Osberger
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20459
Re: Transcend Therapeutics, Inc.
Registration Statement on Form S-1
File No. 333-10599
-----------------------------------
Dear Mr. Osberger:
Transcend Therapeutics, Inc. hereby requests that its Registration
Statement on Form S-1 (File No. 333-10599) initially filed on August 22, 1996
be withdrawn pursuant to Rule 477 promulgated under the Securities Act of 1933,
as amended (the "Act").
Please contact the undersigned at (617-374-1200) or Susan W. Murley at
Hale and Dorr, counsel to the Company (617-526-6832), with any questions.
Best regards.
Very truly yours,
/s/ B. Nicholas Harvey
B. Nicholas Harvey
cc: Susan W. Murley